In this web exclusive, Kate Creevy, of Texas A&M University, and the chief veterinary officer of the Dog Aging Project, talks about the long-term longitudinal study of healthy aging in dogs, including a clinical trial of the drug rapamycin to test its effects on cognitive function, muscle strength, activity levels, and heart health, in the hopes of maximizing a dog’s “health span.”
